Rationale, design, and baseline characteristics in evaluation of LIXisenatide in Acute Coronary Syndrome, a long-term cardiovascular end point trial of lixisenatide versus placebo

Rhonda Bentley-Lewis; David Aguilar; Matthew C. Riddle; Brian Claggett; Rafael Diaz; Kenneth Dickstein; Hertzel C. Gerstein; Peter Johnston; Lars V. Køber; Francesca Lawson; Eldrin F. Lewis; Aldo P. Maggioni; John J. V. McMurray; Lin Ping; Jeffrey L. Probstfield; Scott D. Solomon; Jean-Claude Tardif; Yujun Wu; Marc A. Pfeffer; ELIXA Investigators; Christian Torp-Pedersen

doi:10.1016/j.ahj.2015.02.002

Rationale, design, and baseline characteristics in evaluation of LIXisenatide in Acute Coronary Syndrome, a long-term cardiovascular end point trial of lixisenatide versus placebo

Rhonda Bentley-Lewis, David Aguilar, Matthew C. Riddle, Brian Claggett, Rafael Diaz, Kenneth Dickstein, Hertzel C. Gerstein, Peter Johnston, Lars V. Køber, Francesca Lawson, Eldrin F. Lewis, Aldo P. Maggioni, John J. V. McMurray, Lin Ping, Jeffrey L. Probstfield, Scott D. Solomon, Jean-Claude Tardif, Yujun Wu, Marc A. Pfeffer, ELIXA InvestigatorsChristian Torp-Pedersen

Research output: Contribution to journal › Journal article › Research › peer-review

89 Citations (Scopus)

Original language	English
Journal	American Heart Journal
Volume	169
Issue number	5
Pages (from-to)	631-638.e7
Number of pages	15
ISSN	0002-8703
DOIs	https://doi.org/10.1016/j.ahj.2015.02.002
Publication status	Published - 2015

Access to Document

10.1016/j.ahj.2015.02.002

AUB Link

Search for the material in Aalborg University Library's search engine

Cite this

Bentley-Lewis, R., Aguilar, D., Riddle, M. C., Claggett, B., Diaz, R., Dickstein, K., Gerstein, H. C., Johnston, P., Køber, L. V., Lawson, F., Lewis, E. F., Maggioni, A. P., McMurray, J. J. V., Ping, L., Probstfield, J. L., Solomon, S. D., Tardif, J-C., Wu, Y., Pfeffer, M. A., ... Torp-Pedersen, C. (2015). Rationale, design, and baseline characteristics in evaluation of LIXisenatide in Acute Coronary Syndrome, a long-term cardiovascular end point trial of lixisenatide versus placebo. American Heart Journal, 169(5), 631-638.e7. https://doi.org/10.1016/j.ahj.2015.02.002

@article{b34e43d2b3a84331b7b9af55d982796f,

title = "Rationale, design, and baseline characteristics in evaluation of LIXisenatide in Acute Coronary Syndrome, a long-term cardiovascular end point trial of lixisenatide versus placebo",

author = "Rhonda Bentley-Lewis and David Aguilar and Riddle, {Matthew C.} and Brian Claggett and Rafael Diaz and Kenneth Dickstein and Gerstein, {Hertzel C.} and Peter Johnston and K{\o}ber, {Lars V.} and Francesca Lawson and Lewis, {Eldrin F.} and Maggioni, {Aldo P.} and McMurray, {John J. V.} and Lin Ping and Probstfield, {Jeffrey L.} and Solomon, {Scott D.} and Jean-Claude Tardif and Yujun Wu and Pfeffer, {Marc A.} and {ELIXA Investigators} and Christian Torp-Pedersen",

note = "Copyright {\textcopyright} 2015. Published by Elsevier Inc.",

year = "2015",

doi = "10.1016/j.ahj.2015.02.002",

language = "English",

volume = "169",

pages = "631--638.e7",

journal = "American Heart Journal",

issn = "0002-8703",

publisher = "Mosby, Inc.",

number = "5",

}

Bentley-Lewis, R, Aguilar, D, Riddle, MC, Claggett, B, Diaz, R, Dickstein, K, Gerstein, HC, Johnston, P, Køber, LV, Lawson, F, Lewis, EF, Maggioni, AP, McMurray, JJV, Ping, L, Probstfield, JL, Solomon, SD, Tardif, J-C, Wu, Y, Pfeffer, MA, ELIXA Investigators & Torp-Pedersen, C 2015, 'Rationale, design, and baseline characteristics in evaluation of LIXisenatide in Acute Coronary Syndrome, a long-term cardiovascular end point trial of lixisenatide versus placebo', American Heart Journal, vol. 169, no. 5, pp. 631-638.e7. https://doi.org/10.1016/j.ahj.2015.02.002

Rationale, design, and baseline characteristics in evaluation of LIXisenatide in Acute Coronary Syndrome, a long-term cardiovascular end point trial of lixisenatide versus placebo. / Bentley-Lewis, Rhonda; Aguilar, David; Riddle, Matthew C. et al.
In: American Heart Journal, Vol. 169, No. 5, 2015, p. 631-638.e7.

Research output: Contribution to journal › Journal article › Research › peer-review

TY - JOUR

T1 - Rationale, design, and baseline characteristics in evaluation of LIXisenatide in Acute Coronary Syndrome, a long-term cardiovascular end point trial of lixisenatide versus placebo

AU - Bentley-Lewis, Rhonda

AU - Aguilar, David

AU - Riddle, Matthew C.

AU - Claggett, Brian

AU - Diaz, Rafael

AU - Dickstein, Kenneth

AU - Gerstein, Hertzel C.

AU - Johnston, Peter

AU - Køber, Lars V.

AU - Lawson, Francesca

AU - Lewis, Eldrin F.

AU - Maggioni, Aldo P.

AU - McMurray, John J. V.

AU - Ping, Lin

AU - Probstfield, Jeffrey L.

AU - Solomon, Scott D.

AU - Tardif, Jean-Claude

AU - Wu, Yujun

AU - Pfeffer, Marc A.

AU - ELIXA Investigators

AU - Torp-Pedersen, Christian

PY - 2015

Y1 - 2015

U2 - 10.1016/j.ahj.2015.02.002

DO - 10.1016/j.ahj.2015.02.002

M3 - Journal article

C2 - 25965710

SN - 0002-8703

VL - 169

SP - 631-638.e7

JO - American Heart Journal

JF - American Heart Journal

IS - 5

ER -